“Instead of floating freely and risking uneven distribution, the 2-micron plasmid has evolved a clever trick of hitchhiking,” ...

AGC Biologics, your friendly CDMO expert, today announced a strategic decision about the large-scale single-use technology it will use at its new Yokohama, Japan facility. The CDMO is introducing two ...

For generations, a tiny piece of DNA has mastered the art of inheritance by hijacking the yeast cell’s division machinery, ...

A new study from the Faculty of Medicine at the Hebrew University of Jerusalem sheds light on how bacterial motion influences ...

On the heels of a recent cost-cutting drive that severed much of AmplifyBio’s R&D capacity, the Ohio-based contract ...

Oncolytic adenovirus was engineered for the forced ectopic delivery of peptide-MHC ligand of T cell receptors (TCRs) to ...

CD47-amyloid-β-CD74 signaling is a key driver of adaptive immunosuppression in sepsis, suppressing B cells and impairing ...

The first-of-its-kind in-depth bacterial evolutionary map could pave the way for the development of precision treatments for certain antibiotic-resistant infections, such as urinary tract infections.

Certain antibiotic-resistant infections could be treated with precision medicine in the future, thanks to a new resource mapping plasmids the ultimate vehicle of rapid bacterial evolution.

PLC (AIM: 4BB) (“4basebio”), a company which develops and commercializes the large-scale manufacture of synthetic DNA as well as nanoparticle delivery solutions, today announced that it has received ...

The first-of-its-kind in-depth bacterial evolutionary map could pave the way for the development of precision treatments for ...